NEW YORK (GenomeWeb News) — German 3D protein structure-analysis company Proteros Biostructures this week said that an existing “silent partner” has invested an additional €1 million ($1.3 million) in the company.
 
Proteros, located in Martinsried, also said that the cash from Munich-based BayBG has “permitted” the company to acquire an additional €4.2 million in financing and research funds. Proteros did not disclose the source of this additional funding.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.